ロード中...
Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis
OBJECTIVE: RhoC oncogene is a well characterized marker of metastasis in a majority of invasive cancers, including HNSCC. Elevated RhoC expression has been found to be associated with distant metastasis. Statins are a class of drugs that are used to reduce cholesterol levels by inhibiting HMG-CoA re...
保存先:
| 出版年: | Oral Oncol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4299638/ https://ncbi.nlm.nih.gov/pubmed/23648017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.oraloncology.2013.04.003 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|